Oppenheimer Downgrades Endo Pharmaceuticals Holdings Inc (ENDP) to Perform
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/14/2026
- S&P 500 and Nasdaq end higher on cool inflation data, solid bank earnings
- IBM plunges 19% as memory capex squeeze derails Q2 earnings
- Fed’s Warsh says central bank won’t tolerate high inflation
- Software stocks tumble: High memory prices cannibalize enterprise tech capex
- AstraZeneca stock dips as HSBC downgrades stock on 'tough path ahead'
- IBM misses Q2 targets as mainframe and software sales disappoint
- Verizon planning new round of layoffs this week - Barron’s
- Goldman Sachs Upgrades NIO (NIO) to Buy
- BofA Securities on AppLovin: 'Current valuation appears reasonable'
- Wall Street ends lower as Iran tensions dampen risk appetite; chipmakers drop
Endo Pharma (ENDP) Possibly in Talks to Sell Itself - Reuters
January 30, 2013 2:41 PM ESTEndo Pharmaceuticals Holdings (NASDAQ: ENDP) is ripping higher today as Reuters says the pharma might be in talks to sell itself. The stock is now up over 10 percent on the session.
Interested parties include Warner Chilcott (Nasdaq:... More
UPDATE: Endo Pharma (ENDP) shares paused for volatility
January 30, 2013 2:29 PM EST(Updated - January 30, 2013 2:34 PM EST)
Endo Pharmaceuticals Holdings (NASDAQ: ENDP) shares paused for volatility.
UPDATE - Market chatter has Endo potentially being in talks for a sale, though nothing has been confirmed. Shares were up about 9.5 percent at the pause.... More
